Lantern Pharma Inc.
LTRN
$4.44
-$0.13-2.85%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -19.37% | -17.87% | -14.40% | -15.66% | -13.28% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 54.73% | -47.11% | 1.64% | 2.26% | 48.71% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -26.40% | -- | -- | -20.00% | 148.01% |
Total Current Assets | -17.40% | -17.52% | -15.62% | -15.22% | -10.59% |
|
|||||
Total Current Assets | -17.40% | -17.52% | -15.62% | -15.22% | -10.59% |
Net Property, Plant & Equipment | -22.61% | -17.81% | -14.36% | 27.46% | 10.86% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | 0.00% | 14.69% | 23.55% |
Total Assets | -17.42% | -17.50% | -15.59% | -14.88% | -10.44% |
|
|||||
Total Accounts Payable | 15.21% | 21.14% | -5.23% | 5.29% | 50.14% |
Total Accrued Expenses | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -18.58% | -15.36% | -3.29% | 20.30% | -7.87% |
Total Finance Division Other Current Liabilities | 15.26% | -30.49% | 101.75% | -57.59% | -6.80% |
Total Other Current Liabilities | 15.26% | -30.49% | 101.75% | -57.59% | -6.80% |
Total Current Liabilities | 13.95% | -1.03% | 20.27% | -21.73% | 16.38% |
|
|||||
Total Current Liabilities | 13.95% | -1.03% | 20.27% | -21.73% | 16.38% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -59.58% | -36.74% | -43.83% | 71.85% | 250.64% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 13.38% | -1.46% | 18.65% | -20.63% | 17.30% |
|
|||||
Common Stock & APIC | 0.17% | 0.15% | 0.30% | 0.20% | 0.14% |
Retained Earnings | -5.38% | -5.97% | -8.38% | -6.86% | -8.17% |
Treasury Stock & Other | -63.55% | -14.48% | 708.70% | -283.33% | -447.37% |
Total Common Equity | -25.36% | -20.82% | -20.34% | -14.01% | -13.52% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -25.36% | -20.82% | -20.34% | -14.01% | -13.52% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -25.36% | -20.82% | -20.34% | -14.01% | -13.52% |
|